Latest News

Four factors complicate treating OUD in primary care


 

FROM JAMA NETWORK OPEN

Confidence lacking in treating patients

Dr. Chang said primary care residents in recent years are coming out of medical school with knowledge about treating OUD, but they often run into more experienced physicians who didn’t get training in the treatment so they feel intimidated about initiating the treatment.

At their clinic, Dr. Chang says, they have a nurse dedicated to OUD, which helps alleviate some of the barriers described in the survey. Patients know they can contact a particular person at the clinic who is dedicated to their needs. The nurse can track down patients who may miss appointments or be hard to locate so physicians don’t have to add that to their workload. They can collect fluid samples and connect patients to services.

Dr. Chang says a nurse might say, “I see we had you on (buprenorphine-naloxone) for opioid use disorder but I see you also have cocaine in your urine. How can we keep you safe?”

Having a health team member, whether a nurse or medical assistant or social worker, designated to help with people who need OUD treatment really makes a difference, she says.

People living with addiction “have a lot of needs,” she says, “and they are hard to address in the typical template a primary care provider might have.”

Family medicine, she says, has been more open to adding support staff for this population than other specialties.

Coauthor Andrew J. Saxon, MD, reported grants from the National Institute of Mental Health (NIMH) during the conduct of the study as well as personal fees from Indivior and royalties from UpToDate outside the submitted work. Coauthor John C. Fortney, PhD, reported grants from the Patient-Centered Outcomes Research Institute during the conduct of the study. Coauthor Anna D. Ratzliff, MD, PhD, reported grants from the University of Washington during the conduct of the study and royalties from Wiley outside the submitted work. No other disclosures were reported.

This story was updated on 8/15/2023.

Pages

Recommended Reading

New international guidelines on opioid deprescribing
MDedge Internal Medicine
‘Landmark’ trial shows opioids for back, neck pain no better than placebo
MDedge Internal Medicine
Medical cannabis does not reduce use of prescription meds
MDedge Internal Medicine
‘Body size is not a choice’ and deserves legal protections
MDedge Internal Medicine
Most Americans in favor of regulated therapeutic psychedelics
MDedge Internal Medicine
Women increasingly dying of alcohol-related causes
MDedge Internal Medicine
Nonalcohol substance use disorder tied to bariatric surgery
MDedge Internal Medicine
A new and completely different pain medicine
MDedge Internal Medicine
OxyContin marketing push still exacting a deadly toll, study says
MDedge Internal Medicine
Medications for opioid addiction significantly underutilized
MDedge Internal Medicine